Acetaminophen and Its Link to Autism and ADHD: A New Review
Overview of Acetaminophen
Acetaminophen, known as paracetamol in many regions, is a widely used over-the-counter medication for managing pain and fevers globally.
Government Concerns and Previous Findings
In September 2025, the United States Government issued a warning regarding a potential link between acetaminophen use during pregnancy and an increased risk of autism in children. This statement raised significant alarm among expectant parents.
Recent Meta-Analysis Results
However, a comprehensive meta-analysis reviewing high-quality studies has found no evidence supporting the notion that taking paracetamol as directed during pregnancy is associated with higher risks of autism, ADHD, or intellectual disabilities in children.
Experts from various countries have expressed agreement with these findings, suggesting that when used according to recommendations, paracetamol remains the safest pain relief option for pregnant individuals.
Popularity and Usage Statistics
Acetaminophen, marketed primarily as Tylenol in the United States, is extensively utilized for treating pain and fevers. In the UK alone, approximately 6,300 tonnes of paracetamol are sold annually, which equates to about 70 tablets per person each year. In the U.S., the Consumer Healthcare Products Association reports that 52 million adults (about 23% of the adult population) consume a medication containing acetaminophen weekly.
Expert Opinions on the Findings
The recent investigation conducted by researchers in the U.K. and Europe has assessed a multitude of studies and concluded that there is no evidence linking acetaminophen use during pregnancy to autism, ADHD, or intellectual disabilities.
The findings, published in *The Lancet Obstetrics, Gynaecology and Women’s Health*, reinforce existing guidelines regarding the safety of paracetamol. Dr. Anand Singh, a consultant gynecologist and obstetrician at the Cadogan Clinic in London, who was not involved in the review, commented on the study’s significance.
“From an obstetric standpoint, this is a reassuring and methodologically strong study which essentially addressed major limitations of earlier work: biases towards existing genetics, family environment, and the underlying reasons paracetamol is used — such as infection, fever, or pain,” Dr. Singh stated in an interview with Medical News Today.
He added, “The absence of an association between antenatal paracetamol exposure and autism spectrum disorder, ADHD, or intellectual disability across these high-quality analyses strongly suggests that previously reported links were not causal. This aligns with what many clinicians have observed in practice and with the conclusions of large national registry studies.”